COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Protocol No
NMDP-ACCESS
Principal Investigator
Saurabh Chhabra
Phase
II
Summary
This study is being done to see to see how well transplant works in adults with a MMUD using stem cells from a donor's blood.
Description
HLA-Mismatched Unrelated Donor HCT with Post-Transplantation Cyclophosphamide (Access)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL